Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:May 16, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:May 16, 2017Completed
Condition(s):Colorectal CancerLast Updated:October 31, 2014Completed
Condition(s):Metastatic Colorectal CancerLast Updated:April 10, 2019Completed
Condition(s):Metastatic Colorectal CancerLast Updated:December 2, 2015Completed
Condition(s):Rectal CancerLast Updated:May 7, 2015Completed
Condition(s):Colorectal CancerLast Updated:May 27, 2015Completed
Condition(s):Colorectal CancerLast Updated:July 13, 2017Terminated
Condition(s):Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer; Adenocarcinoma of the Colon; Adenocarcinoma of the RectumLast Updated:June 8, 2015Completed
Condition(s):Colorectal CancerLast Updated:February 12, 2021Completed
Condition(s):Colorectal NeoplasmsLast Updated:June 9, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.